National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

norgestrel
A synthetic progestin commonly used alone or in combination with an estrogen for contraception. Norgestrel suppresses the secretion of luteinizing and follicle-stimulating hormones (LH and FSH), thickens cervical mucus, and slows the transit of ova through the fallopian tubes. This agent also exhibits antiproliferative activity in endometrial tissue and may exhibit chemopreventive and antineoplastic activities in endometrial carcinoma. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:D-(-)-Norgestrel
Levonorgestrel
US brand names:Neogest
Ovrette
Foreign brand name:Microlut
Abbreviation:NORGES
Code name:Wy-3707
Chemical structure names:
  • (+/-)-13-ethyl-17alpha-hydroxy-18,19-dinorpregn-4-en-20-yne-3-one
  • (17alpha)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one



Previous:NMPRTase inhibitor APO866, nolatrexed dihydrochloride, Nolvadex, nordihydroguaiaretic acid, norethindrone acetate
Next:Norlutate, Norlutin, Norplant, Norvir, noscapine hydrochloride

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov